PKM and hepatocellular carcinoma: We found that HCC patients with a higher expression of PKM2 demonstrated a lower degree of differentiation (poor and moderate differentiation, 86.8% versus 55.9%, p = 0.015) and a larger volume (tumor size ≥5 cm, 89.1% versus 58.8%, p = 0.010) of tumor tissue.